$OCGN I'm new, didn't Shankar Musunari lead the team at Pfizer that got FDA approval??? Is that kinda good? Prevnar hit $5.95 billion in sales in 2019, making it Pfizer's best-selling solo medicine—unlike blood thinner Eliquis, which is co-marketed with Bristol Myers Squibb. In 2026, the year Prevnar loses patent protection, Evaluate Pharma forecasts the shot will rake in $7.06 billion in sales.
5
8
8 Likes